Every Form 4 that The Sherwin-Williams Company (SHW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SHW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SHW filings page.
Sherwin-Williams Co. (SHW) director Thomas Williams acquired 104.12 deferred stock units on October 2, 2026, in an exempt transaction under the 2005 Director Deferred Fee Plan. The transaction-date weighted average share price of $324.14 was used to determine the number of units credited. The Deferred Fee Plan position after the acquisition was 1,369.35 deferred stock units, including units acquired through the plan’s dividend reinvestment feature. A separate line for previously reported direct holdings lists 1,100 restricted stock units and 1,271 common shares.
Sherwin Williams Co. (SHW) director Michael H. Thaman acquired 104.12 deferred stock units on October 2, 2026, under the 2005 Director Deferred Fee Plan. The $324.14 weighted average share price was used to determine the number of units credited. The units are economically equivalent to common shares and payable solely in stock, generally after his separation from service as a director. No Rule 10b5-1 plan is reported. His indirect deferred stock unit holdings afterward were 5,830.87 units. A separate previously reported direct holding line lists 1,100 restricted stock units and 7,011 common shares.
Sherwin-Williams director Robert James Gamgort acquired 104.12 deferred stock units on October 2, 2026, in an exempt transaction under the 2005 Director Deferred Fee Plan. The units are the economic equivalent of common shares and are payable solely in stock, generally following his separation from service as a director. His reported indirect deferred-unit balance after the acquisition was 691.12. A separate, previously reported direct holding comprised 1,075 securities: 902 restricted stock units and 173 common shares.
Sherwin-Williams (SHW) director Kerrii B. Anderson acquired 30.85 deferred stock units on October 2, 2026, under the 2005 Director Deferred Fee Plan. The $324.14 weighted-average share price was used to determine the number of units credited. The units are payable solely in stock, generally following her separation from service as a director; her reported deferred-unit balance afterward was 1,109.95. No Rule 10b5-1 plan is reported. A separate, previously reported holding entry lists 5,819 securities: 1,100 restricted stock units and 4,719 common shares.
SHERWIN WILLIAMS CO (SHW) executive Justin T. Binns, President, Glob. Architectural, reported multiple transactions in Sherwin-Williams common stock. On August 17, 2026, he exercised 13,500 stock options with a $90.04 exercise price, receiving an equal number of common shares, and on the same date sold 13,500 shares at a weighted average price of about $352.70 per share in multiple trades between $353.01 and $352.66.
On August 18, 2026, he made a bona fide gift of 813 shares to a charitable donor advised fund. Following these transactions, 6,009.63 shares of common stock are attributable to his participation in The Sherwin-Williams Company 401(k) Plan, reported as indirect ownership. The exercised options, granted in 2016, are now fully exhausted according to this report.
Sherwin-Williams Company officer Karl J. Jorgenrud, President, Global Industrial, reported several equity transactions on 2026-08-07. He exercised 90 stock options at an exercise price of $127.98 per share, receiving 90 shares of common stock. On the same date, he sold 7,886 shares of Sherwin-Williams common stock at $368.30 per share in a sale transaction. Following the option exercise, he held 4,260 employee stock options directly, expiring 2027-10-17, and had 1,252.54 shares of common stock attributable to his participation in The Sherwin-Williams Company 401(k) Plan as of 2026-06-30. The transactions are not indicated as being made pursuant to a Rule 10b5-1 trading plan.
Sherwin-Williams director Thomas Williams reported a compensation-related equity award rather than an open-market trade. He acquired 96.32 deferred stock units of common stock at a weighted average reference price of $350.40 per unit under the 2005 Director Deferred Fee Plan, in an exempt transaction. These units are economically equivalent to common shares and will generally be paid in stock after he leaves the board.
Following this award, Williams now indirectly holds 1,262.09 deferred stock units under the Deferred Fee Plan. Separately, he directly holds 2,371 common-stock-related interests, consisting of 1,334 restricted stock units and 1,037 shares of common stock, reflecting his ongoing equity-based stake in the company.
The Sherwin-Williams Company director Michael H. Thaman acquired 96.32 deferred stock units of common stock on July 6, 2026 at a weighted average price of $350.40 per share under the 2005 Director Deferred Fee Plan. Each deferred stock unit is the economic equivalent of one share of common stock and will be paid solely in stock, generally after he leaves the board. Following this grant, he holds 5,712.57 deferred stock units indirectly through the plan and 8,111 equity interests directly, consisting of 1,100 restricted stock units and 7,011 shares of common stock.
Sherwin-Williams director Robert James Gamgort reported a compensation-related stock award. He acquired 96.32 deferred stock units of common stock on July 6, 2026 in an exempt transaction under the company’s 2005 Director Deferred Fee Plan, at a weighted average price of $350.40 per unit.
Each deferred stock unit is economically equivalent to one share of common stock and will be settled in stock, generally after he leaves the board. Following this award, his Deferred Fee Plan account holds 585.55 deferred stock units held indirectly, while a separate line reflects 1,075 directly held shares previously reported.
Sherwin-Williams director Kerrii B. Anderson received an award of deferred stock units under the company’s 2005 Director Deferred Fee Plan. She acquired 28.54 deferred stock units, each economically equivalent to one share of common stock, based on a weighted average share price of $350.40.
These units are held indirectly through the Deferred Fee Plan and become payable in stock, generally after she leaves the board. Following this award, she holds 1,076.42 deferred stock units under the plan, and separately has 5,819 direct equity interests, consisting of 1,100 restricted stock units and 4,719 common shares.
Williams Thomas reported acquisition or exercise transactions in this Form 4 filing.
Sherwin-Williams director Thomas Williams received an award of 106.970 deferred stock units of common stock on April 6, 2026, in an exempt transaction under the 2005 Director Deferred Fee Plan. The weighted average share price used to determine this grant was $315.50 per share.
Each deferred stock unit is economically equivalent to one share of common stock and will be paid solely in stock, generally after he leaves the board. Following this grant, he indirectly holds 1,162.730 deferred stock units under the plan and, in a separate direct position, 2,371.000 common stock-related securities, including 1,334 restricted stock units and 1,037 shares.
Sherwin-Williams director Michael H. Thaman received an equity-based compensation award in the form of deferred stock units tied to the company’s common stock. On the transaction date, he acquired 106.97 deferred stock units under the 2005 Director Deferred Fee Plan at a weighted average price reference of $315.50 per unit.
Each deferred stock unit is economically equivalent to one share of common stock and will be settled in stock, generally after he leaves the board. Following this grant, he indirectly holds 5,601.56 deferred stock units in the Deferred Fee Plan and directly holds 8,111 common-related units, consisting of 1,100 restricted stock units and 7,011 shares of common stock. No open-market purchases or sales were reported, and no derivative securities remain outstanding in this filing.
SHERWIN WILLIAMS CO director Robert James Gamgort acquired 106.97 deferred stock units of common stock in an exempt award under the company’s 2005 Director Deferred Fee Plan. Each deferred stock unit is economically equivalent to one common share and is generally payable in stock after he leaves the board.
Following this grant, he indirectly holds 487.96 deferred stock units under the Deferred Fee Plan and continues to hold 1,075 restricted stock units directly, each representing the right to receive one common share. No open‑market purchases or sales were reported in this filing.
ANDERSON KERRII B reported acquisition or exercise transactions in this Form 4 filing.
Sherwin-Williams director Kerrii B. Anderson received a grant of deferred stock units tied to company common stock as part of director compensation. On this date, 31.7 deferred stock units were credited to her account under the 2005 Director Deferred Fee Plan, using a weighted average price of $315.50 per share to determine the number of units.
Each deferred stock unit is economically equivalent to one share of common stock and will be paid solely in stock, generally after she leaves the board. Following this grant, she holds 1,045.15 deferred stock units indirectly under the Deferred Fee Plan and 5,819 common share-related interests directly, consisting of 1,100 restricted stock units and 4,719 shares of common stock.
Sherwin-Williams Company senior vice president Bryan J. Young reported an open-market sale of Common Stock. On February 24, 2026, he sold 2,513 shares at an average price of $364.47 per share. After this sale, he directly held 10,045 shares and had 519 shares attributable to his participation in The Sherwin-Williams Company 401(k) Plan, based on the trustee’s February 13, 2026 statement.
The Sherwin-Williams Company senior vice president Bryan J. Young reported equity compensation activity involving the company’s common stock. He acquired 3,900 shares through the vesting and payout of a performance-based restricted stock unit award granted on February 14, 2023 for the 2023–2025 performance period.
To cover tax withholding obligations from this vesting, 1,387 shares were mandatorily withheld by the company at a price of $368.59 per share, a tax-withholding disposition rather than an open-market sale. Following these transactions, Young directly owned 12,558 shares, and an additional 519 shares were attributable to his participation in The Sherwin-Williams Company 401(k) Plan.
Sherwin-Williams President, Consumer Brands Group Todd D. Rea reported equity award activity in company stock. He acquired 5,100 shares of Common Stock on a grant/award basis at a stated price of $0.0000 per share, reflecting the payout of a performance-based restricted stock unit (PRSU) award granted on February 14, 2023 and tied to performance conditions for the 2023–2025 period.
To cover related tax withholding obligations upon vesting of this PRSU award, 1,883 shares of Common Stock were disposed of at $368.5900 per share through a tax-withholding disposition, rather than an open-market sale. Following these transactions, he directly held 12,546 shares of Common Stock. Separately, 5,407.03 shares are attributable to his participation in The Sherwin-Williams Company 401(k) Plan.
The Sherwin-Williams Company President & CEO Heidi G. Petz reported equity compensation changes involving the company’s common stock. On February 17, 2026, she acquired 16,800 shares of common stock at $0.00 per share as a vested performance-based restricted stock unit (PRSU) award for the 2023–2025 performance period under the company’s equity and performance incentive plan. On the same date, 7,494 shares of common stock were disposed of at $368.5900 per share, representing shares mandatorily withheld by the company to cover tax withholding obligations triggered by the PRSU vesting. Following these transactions, she directly owned 26,468 shares of common stock and indirectly held 376.7800 shares through participation in The Sherwin-Williams Company 401(k) Plan.
Sherwin-Williams SVP Finance and CFO Benjamin E. Meisenzahl reported equity compensation activity in company common stock. He acquired 960 shares at $0.00 per share as a vested performance-based restricted stock unit award covering the 2023–2025 period. To cover taxes on this vesting, 296 shares were mandatorily withheld at $368.59 per share rather than sold on the open market. After these transactions, he directly holds 6,337.4 shares of common stock and has an additional 257.12 shares through The Sherwin-Williams Company 401(k) Plan per the trustee’s 2/13/2026 statement.
The Sherwin-Williams Company senior vice president James P. Lang reported equity compensation activity in company stock. On the reported date, he acquired 714 shares of common stock through the vesting and payout of a performance-based restricted stock unit award, at no cash price. In connection with this vesting, 230 shares were mandatorily withheld by the company at $368.59 per share to cover related tax obligations, a non–open-market disposition. Following these transactions, he directly holds 861 shares of common stock and has an additional 1,038.56 shares attributable to his participation in The Sherwin-Williams Company 401(k) Plan.
The Sherwin-Williams Company president of Global Industrial, Karl J. Jorgenrud, reported equity compensation activity involving common stock. On February 17, 2026, a performance-based restricted stock unit (PRSU) award granted on February 14, 2023 for the 2023–2025 performance period vested and paid out in 9,600 shares of common stock, recorded as an acquisition at $0.00 per share.
The company mandatorily withheld 4,379 shares at $368.59 per share to cover Jorgenrud’s tax liabilities upon vesting, reported as a tax-withholding disposition rather than an open-market sale. After these transactions, he directly held 19,739.84 shares of common stock and had an additional 1,180.08 shares attributable to his participation in The Sherwin-Williams Company 401(k) Plan, based on the plan trustee’s February 13, 2026 statement.
The Sherwin-Williams Company senior vice president James R. Jaye reported equity compensation activity involving common stock. On February 17, 2026, a performance-based restricted stock unit (PRSU) award granted on February 14, 2023 vested for the 2023–2025 performance period, resulting in an acquisition of 2,100 shares of common stock at no cost under the company’s 2006 Equity and Performance Incentive Plan.
To cover tax withholding liabilities from this vesting, 639 shares of common stock were mandatorily withheld by Sherwin-Williams at $368.59 per share, reducing directly held shares to 5,536.57. In addition, 147.68 shares are attributed to Jaye’s participation in the Sherwin-Williams 401(k) Plan, and his reported direct holdings include 36.35 shares acquired through dividend reinvestment.
Sherwin-Williams senior vice president and chief legal officer Mary L. Garceau reported equity compensation activity in company common stock. She acquired 9,000 shares at a stated price of $0.0000 through a performance-based restricted stock unit award that vested based on 2023–2025 performance conditions. On the same date, 3,618 shares at $368.5900 per share were withheld by the company to cover her tax obligations from this vesting, meaning these were not open-market sales. Following these transactions, she directly held 35,357 shares of common stock and indirectly held 901.97 shares through The Sherwin-Williams Company 401(k) Plan.
The Sherwin-Williams Company executive Colin M. Davie reported equity compensation activity involving company common stock. He acquired 3,300 shares on a grant or award basis at $0.0000 per share, tied to a performance-based restricted stock unit (PRSU) award that vested for the 2023–2025 performance period.
To cover related tax withholding obligations upon this PRSU vesting, 1,346 shares were disposed of at $368.5900 per share through a tax-withholding transaction, rather than an open-market sale. After these transactions, he directly owned 7,319 common shares, and an additional 563.36 shares were held indirectly through The Sherwin-Williams Company 401(k) Plan as of the trustee’s 2/13/2026 statement.
Sherwin-Williams Company senior vice president and CHRO Marlena K. Boyce reported equity compensation activity in company stock. On February 17, 2026, she acquired 1,338 shares of common stock at $0.00 per share from a performance-based restricted stock unit (PRSU) award granted on February 14, 2023 for the 2023–2025 performance period. To cover tax withholding on this vesting, 411 shares were mandatorily surrendered back to the company at $368.59 per share, a tax-withholding disposition rather than an open-market sale. After these transactions, she directly owned 1,285 shares of Sherwin-Williams common stock.
Sherwin-Williams executive Justin T. Binns reported equity compensation activity involving common stock. He acquired 9,900 shares through the vesting and payout of a performance-based restricted stock unit (PRSU) award covering the 2023–2025 performance period, granted under the company’s equity and performance incentive plan.
To cover tax withholding on this vesting, 4,416 shares were mandatorily withheld by the company at a price of $368.59 per share, a non-open-market, tax-withholding disposition. After these transactions, he directly holds 21,937 common shares and has an additional 5,922.35 shares attributable to his participation in The Sherwin-Williams Company 401(k) Plan.
Director Thomas Williams reported an acquisition of 558 shares of Sherwin-Williams common stock on a grant of restricted stock units under the 2025 Equity and Incentive Compensation Plan. Each RSU equals one share of common stock and vests in three annual installments starting February 16, 2027.
After this award, Williams holds 2,371 shares of Sherwin-Williams common stock directly and 1,053.14 deferred stock units indirectly through the 2005 Director Deferred Fee Plan, which also accumulates units via a dividend reinvestment feature.
Sherwin-Williams director Aaron Powell reported an equity award tied to 558 shares of Common Stock on February 17, 2026. The filing classifies this as an acquisition granted at a price of $0.00 per share under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan.
The award is in the form of restricted stock units, each representing the right to receive one share of Common Stock. These RSUs vest annually in three substantially equal installments starting on February 16, 2027. After this grant, Powell beneficially owns 3,587 shares in total, consisting of 1,100 RSUs and 2,487 shares of Common Stock held directly.
The Sherwin-Williams Company director Matthew Thornton III received an equity award in the form of restricted stock units that convert into common stock. On February 17, 2026, he acquired 558 shares of common stock at a price of $0 per share as part of this grant.
The award was made under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. The restricted stock units vest in three substantially equal annual installments starting on February 16, 2027. Following this transaction, he beneficially owned 12,854 common shares, including 1,100 RSUs and 11,754 shares of common stock.
THAMAN MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.
Sherwin-Williams director Michael H. Thaman reported an award of 558 restricted stock units, each representing one share of Common Stock, granted at $0 under the 2025 Equity and Incentive Compensation Plan. The RSUs vest in three annual installments starting on February 16, 2027. After this grant, he beneficially owns 8,111 shares and RSUs directly and 5,480.97 deferred stock units indirectly through the 2005 Director Deferred Fee Plan.
STEWART MARTA R reported acquisition or exercise transactions in a Form 4 filing for SHW. The filing lists transactions totaling 558 shares. Following the reported transactions, holdings were 3,484 shares.
Gamgort Robert James reported acquisition or exercise transactions in this Form 4 filing.
Sherwin-Williams director Robert James Gamgort reported receiving a grant of 558 restricted stock units (RSUs) of Common Stock on February 17, 2026 at a reported price of $0 per share under the 2025 Equity and Incentive Compensation Plan. Each RSU represents one share of Sherwin-Williams common stock and will vest in three substantially equal annual installments starting on February 16, 2027. After this grant, Gamgort beneficially owns 1,075 RSUs directly, and separately holds 380.04 deferred stock units indirectly through the 2005 Director Deferred Fee Plan, including units accumulated via dividend reinvestment.
Sherwin-Williams director Jeff M. Fettig reported an equity award from the company. On February 17, 2026, he acquired 558 shares of Common Stock at $0 as part of a grant of restricted stock units under the 2025 Equity and Incentive Compensation Plan. The RSUs vest in three substantially equal annual installments starting February 16, 2027. After this award, he beneficially owns 7,019 shares, consisting of 1,100 RSUs and 5,919 shares of Common Stock.
The Sherwin-Williams Company director Kerrii B. Anderson received an equity grant in the form of restricted stock units. On February 17, 2026, Anderson was awarded 558 shares of Sherwin-Williams common stock at a price of $0, as a grant, award, or other acquisition under the company’s 2025 Equity and Incentive Compensation Plan.
After this grant, Anderson directly beneficially owned 5,819 common shares, which the filing notes consist of 1,100 restricted stock units and 4,719 shares of common stock. In addition, Anderson indirectly held 1,010.94 deferred stock units through the 2005 Director Deferred Fee Plan, including units accumulated via dividend reinvestment.
The Sherwin-Williams Company executive reports a routine tax-related share disposition. President, Global Architectural Justin T. Binns had 1,469 shares of common stock mandatorily withheld at $372.49 per share on February 13, 2026 to cover tax obligations upon vesting of 4,175 restricted stock units granted in 2023.
After this tax-withholding disposition, he directly beneficially owns 16,453 common shares and indirectly holds 5,922.35 shares through The Sherwin-Williams Company 401(k) Plan. The filing reflects compensation-related equity activity rather than an open-market trade.
Sherwin-Williams executive Karl J. Jorgenrud reported a tax-related share disposition in company stock. As President, Global Industrial, he had 1,510 shares of Sherwin-Williams common stock mandatorily withheld on February 13, 2026 to cover tax obligations arising from the vesting of 4,175 restricted stock units granted on February 14, 2023.
These withheld shares were valued at $372.49 per share. After this tax-withholding disposition, Jorgenrud directly beneficially owned 14,518.84 shares of common stock and indirectly held 1,180.08 shares through The Sherwin-Williams Company 401(k) Plan, based on the trustee’s February 13, 2026 statement.
Sherwin-Williams President & CEO Heidi G. Petz reported a tax-related share disposition tied to equity compensation. On February 13, 2026, 3,322 shares of Common Stock were disposed of at $372.49 per share through a tax-withholding disposition, where shares were mandatorily withheld by the company to cover taxes upon vesting of 8,350 restricted stock units granted in 2023.
After this transaction, Petz directly beneficially owned 17,162 shares of Common Stock, and indirectly held 376.78 shares through participation in The Sherwin-Williams Company 401(k) Plan as of the trustee’s February 13, 2026 statement.
Sherwin-Williams executive Davie Colin M., President & GM, Global Supply Chain, reported stock transactions dated February 2, 2026. He exercised an employee stock option for 2,976 shares of common stock at an exercise price of $127.98 per share, then sold 2,976 shares of common stock at a weighted average price of $359.50 per share. Following these trades, he directly owned 5,365 shares of Sherwin-Williams common stock and held an additional 559.64 shares indirectly through The Sherwin-Williams Company 401(k) Plan as of the plan’s December 31, 2025 statement. The option position reported was reduced to zero after the exercise.
The Sherwin-Williams Company director Thomas Williams reported an automatic equity award under a director fee plan. On 01/09/2026 he acquired 97.66 deferred stock units tied to Sherwin-Williams common stock through the 2005 Director Deferred Fee Plan, using a weighted average share price of $345.60 to calculate the units. Each deferred stock unit is economically equal to one share of common stock and will be paid in stock, generally after he leaves the board. After this transaction, he held a total of 1,053.14 deferred stock units indirectly under the Deferred Fee Plan, and 1,813 directly held equity interests made up of 1,147 restricted stock units and 666 shares of common stock.
Sherwin-Williams director Michael H. Thaman reported an automatic grant of deferred stock units under the company’s 2005 Director Deferred Fee Plan. On January 9, 2026, he acquired 97.66 deferred stock units linked to Sherwin-Williams common stock at a weighted average share price of $345.6, in an exempt transaction under this plan. After this credit, he held 5,480.97 deferred stock units indirectly in the Deferred Fee Plan, which will generally be paid out in stock after he leaves the board. He also reported 7,553 securities held directly, consisting of 1,150 restricted stock units and 6,403 shares of common stock, where each RSU represents the right to receive one share.
The Sherwin-Williams Company director Robert James Gamgort reported acquiring additional deferred stock units linked to the company’s common stock. On 01/09/2026, he received 97.66 deferred stock units in an exempt transaction under the 2005 Director Deferred Fee Plan, based on a weighted average share price of $345.6. Each deferred stock unit is economically equivalent to one share and is payable in stock, generally after his service as a director ends.
Following this transaction, Gamgort held 380.04 deferred stock units under the Deferred Fee Plan on an indirect basis and separately held 517 restricted stock units directly, each RSU representing the right to receive one share of common stock.
Sherwin-Williams director Kerrii B. Anderson reported a small equity award. On January 9, 2026, the director acquired 28.94 deferred stock units of Sherwin-Williams common stock in an exempt transaction under the company’s 2005 Director Deferred Fee Plan. These deferred stock units are economically equivalent to common shares and are credited at a weighted average share price of $345.60, becoming payable in stock, generally after the director leaves the board.
Following this transaction, Anderson indirectly holds 1,010.94 deferred stock units under the Deferred Fee Plan. The director also directly holds 5,261 securities, consisting of 1,150 restricted stock units and 4,111 shares of common stock, where each restricted stock unit represents the right to receive one share.
Sherwin-Williams (SHW) senior vice president, finance & CFO reported several equity transactions on 12/01/2025. The filing shows exercises of employee stock options to buy 338 shares at $295.83 and 464 shares at $215.08, coded as option exercises (M). Related dispositions of 290 shares at $344.17 and 289 shares at $344.32 were reported with code F, indicating shares withheld or sold to cover taxes.
After these transactions, the executive directly owns 13,273–13,562 shares of common stock, which include 8,350 restricted stock units and varying common share amounts as explained in the footnotes. The filing also reports 1,175.56 shares in a 401(k) plan, 38,500 shares held by a trust, and 20,974 shares held by the spouse, all reported as indirect ownership. Remaining employee stock options total 15,662 and 14,336 options from grants made in October 2021 and October 2022, which vested in three annual installments.
Sherwin-Williams (SHW) reported an insider equity grant for a senior executive. The company granted 10,860 employee stock options to its President, Global Industrial on October 20, 2025, at an exercise price of $331.37 per share. These options vest in three substantially equal annual installments beginning October 20, 2026, and expire on October 19, 2035. Following the transaction, the executive beneficially owned 10,860 derivative securities directly.
Sherwin-Williams (SHW) reported an insider equity grant. The company’s President & CEO, who is also a director, received 47,630 employee stock options on October 20, 2025 at an exercise price of $331.37 per share. These options expire on October 19, 2035 and vest in three substantially equal annual installments beginning October 20, 2026, pursuant to the 2025 Equity and Incentive Compensation Plan. No open-market stock sales or purchases were reported.
Sherwin-Williams (SHW) reported an insider equity award on Form 4. The company granted its SVP–Finance & CFO an employee stock option for 16,920 shares at an exercise price of $331.37 per share on October 20, 2025, under the 2025 Equity and Incentive Compensation Plan.
The options vest annually in three substantially equal installments commencing October 20, 2026, and carry an expiration date of October 19, 2035. Following the reported transaction, the reporting person holds 16,920 derivative securities directly.
Sherwin-Williams (SHW) disclosed a Form 4 showing its President, Global Architectural, received an employee stock option grant for 10,860 shares at an exercise price of $331.37 on October 20, 2025.
The options expire on October 19, 2035 and vest annually in three substantially equal installments starting October 20, 2026. After the grant, 10,860 derivative securities are listed as directly owned.
Sherwin-Williams (SHW) reported an equity compensation grant to an officer. On October 20, 2025, the SVP - CLO and Secretary was awarded 7,940 employee stock options with an exercise price of $331.37 per share. The options were granted under the company’s 2025 Equity and Incentive Compensation Plan and carry no purchase price at grant.
The options vest annually in three substantially equal installments commencing October 20, 2026, and expire on October 19, 2035. Ownership is listed as Direct.
Sherwin-Williams (SHW) disclosed an officer stock option grant in a Form 4. The filing reports an award of 6,270 employee stock options on October 20, 2025 at an exercise price of $331.37 per share. The officer is identified as Pres. & GM, Glob. Supply Chain.
The options were granted under the 2025 Equity and Incentive Compensation Plan and vest annually in three substantially equal installments commencing October 20, 2026. The options expire on October 19, 2035. Following the reported transaction, 6,270 derivative securities were beneficially owned, with direct ownership indicated.
Sherwin-Williams (SHW) reported an insider equity grant: its SVP–CHRO received 6,060 employee stock options with an exercise price of $331.37 per share on October 20, 2025, under the 2025 Equity and Incentive Compensation Plan.
The options vest in three substantially equal annual installments starting October 20, 2026, and expire on October 19, 2035. This is a standard compensation award that sets the right to buy common stock at a fixed price over time as service-based vesting conditions are met.